OSM and cancer: A recent screen of TME cytokines identified oncostatin-M (OSM), a member of the IL-6 superfamily, as a potent inducer of cancer cell de-differentiation, resulting in the acquisition of CSC markers and biological properties (including tumor-initiating capacity, metastatic outgrowth, and drug resistance [2–4]).